# Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

> **NCT00413049** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 698 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Valsartan/amlodipine 80/5 mg
- **DRUG:** Amlodipine 5 mg

## Key facts

- **NCT ID:** NCT00413049
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 698 (ACTUAL)
- **Last updated:** 2011-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413049, "Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00413049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*